FundingWatcher
Home / Startups / Top biotech startups / Biotech startups that raised Series A / Biotech startups that raised Series A in California, United States

Biotech startups that raised Series A in California, United States

Updated 16 Nov 2026

Reset
Biotech startups that raised Series A in California, United States
One-time CSV
  • 366 funded companies, 322 with a website
  • Last round, amount, date, total raised and investors
  • CRM-ready CSV, 18 columns
  • Download right after payment
With founder contacts
Compiled to order
  • The full startup CSV, plus founders and executives
  • Up to 2 founders or CEOs per company, compiled to order
  • Name, job title and LinkedIn URL where found
  • Verified direct email per person
  • Startup CSV at once, contacts CSV by mail within 24 hours
Download right after paymentFree 10-row sampleSecure checkout by Stripe

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

startups-biotech--series-a~california-united-states.csv366 rows × 18 columns
CompanyCityLast roundAmountDate
ZafrensSan DiegoSeries A$6.0M2026-11-03
Probably GeneticSan FranciscoSeries A$12.0M2026-10-15
ImpriMedPalo AltoSeries A$10.0M2026-09-18
MithrlSan FranciscoSeries A$20.0M2026-09-15
TwoStep TherapeuticsPalo AltoSeries A$62.5M2026-09-09
Integrated BiosciencesRedwood CitySeries A$68.4M2026-08-05
Transcripta BioPalo AltoSeries A$24.0M2026-07-22
Condor SoftwareSan DiegoSeries A$24.0M2026-03-18

8 rows of the CSV in 5 of its 18 columns.

366
Startups
$17.3B
Total raised
47
Funded in the last 12 months
$2.3B
Raised in the last 12 months

Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.

Newest rounds

30 of 366
30 rows
Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego Series A $6.0M 2026-11-03 $35.0M Liquid 2 Ventures, Global Brain Corporation, BlueYard Capital +2 11 to 50 2022
Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence San Francisco Series A $12.0M 2026-10-15 $22.9M Y Combinator, Khosla Ventures, TenOneTen Ventures +2 11 to 50 2018
ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Palo Alto Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017
Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence San Francisco Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
Integrated Biosciences Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. Artificial intelligence Redwood City Series A $68.4M 2026-08-05 $85.6M Root Ventures, Reinforced Ventures, Mission BioCapital +2 11 to 50 2022
Transcripta Bio Transcripta Bio develops drugs at an accelerated pace with reduced risk. Biotech Palo Alto Series A $24.0M 2026-07-22 $34.4M BlueYard Capital, Jazz Venture Partners 11 to 50 2020
Condor Software Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time. Biotech San Diego Series A $24.0M 2026-03-18 $29.5M Plug and Play, MassChallenge, Pareto Holdings +1 11 to 50 2020
Medra AI Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. Artificial intelligence San Francisco Series A $52.0M 2025-12-11 $63.0M PharmStars 11 to 50 2021
Perelel Perelel makes supplements designed for different stages of a woman's reproductive life cycle. Biotech Los Angeles Series A $27.0M 2025-11-20 $41.7M Unilever Ventures, Willow Growth Partners, Selva Ventures 11 to 50 2018
Mosanna Therapeutics Mosanna Therapeutics develops a nasal spray for treating obstructive sleep apnea. Biotech Redwood City Series A $80.0M 2025-06-09 $80.0M HTGF (High-Tech Gruenderfonds), Supermoon Capital 1 to 10 2022
Persist AI Persist AI is a biotechnology company that develops long-acting microsphere drug formulations. Artificial intelligence Woodland Series A $12.0M 2025-03-19 $16.5M Y Combinator, Pioneer Fund, 2048 Ventures +2 11 to 50 2022
Trace Neuroscience Trace Neuroscience aims to extend the promise of genetic medicine to patients. Biotech South San Francisco Series A $101.0M 2024-11-12 $101.0M RA Capital Management, Atlas Venture, Third Rock Ventures 11 to 50 2024
Oloid Oloid provides passwordless access for frontline workers and shared devices. Biotech Sunnyvale Series A $6.0M 2024-10-24 $23.0M Plug and Play, Unusual Ventures, WestWave Capital +2 51 to 100 2019
MiLaboratories MiLaboratories is a biotech company that develops software for immune repertoire profiling. Biotech Sunnyvale Series A $10.0M 2024-10-10 $12.4M Speedinvest, K Fund, Acrobator Ventures +2 11 to 50 2021
Shinobi Therapeutics Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment. Biotech South San Francisco Series A $68.0M 2024-08-06 $178.0M Mitsubishi UFJ Capital, F-Prime, EQT Life Sciences +2 11 to 50 2023
NGM Biopharmaceuticals NGM Biopharmaceuticals discovers and develops biotherapeutics for gastrointestinal and endocrine disorders. Biotech South San Francisco Series A $122.0M 2024-07-17 $542.4M Rho Capital Partners, Greenspring Associates, The Column Group 11 to 50 2008
Digestiva Digestiva develops food and feed proteins with improved nutritional and sensory properties using targeted biocatalysts. Biotech Sacramento Series A $18.4M 2024-07-15 $18.4M Astanor Ventures, UC Investments 11 to 50 2018
Immunis Immunis is a private biotechnology company developing a treatment for age and disease-related immune decline. Biotech Irvine Series A $25.0M 2024-07-01 $35.0M Healthspan Capital, Remiges Ventures, Continuum Health Ventures 11 to 50 2018
Raydiant Oximetry Raydiant Oximetry makes medical devices that improve outcomes for mothers and babies during childbirth. Biotech San Ramon Series A $7.5M 2024-06-04 $25.6M National Science Foundation, Enterprise Ireland, National Institutes of Health +1 11 to 50 2016
Xaira Therapeutics Unicorn Xaira Therapeutics applies artificial intelligence to drug discovery and biotechnology research. Artificial intelligence South San Francisco Series A $1.0B 2024-04-23 $1.0B Sequoia Capital, New Enterprise Associates, Menlo Ventures +2 101 to 250 2023
Kryptos Biotechnologies Kryptos Biotechnologies provides life science systems that reveal the complexity of biology for clinicians and scientists. Biotech Hayward Series A $10.0M 2024-03-28 $21.8M SkyDeck Berkeley, FuturePlay, KDB Capital 1 to 10 2017
Argonaut Manufacturing Services Argonaut Manufacturing Services provides contract manufacturing for biopharmaceutical, diagnostics, and life science organizations. Biotech Carlsbad Series A $45.0M 2024-03-05 $67.3M Square 1 Bank, Telegraph Hill Partners, NewVale Capital 51 to 100 2016
CRISPR QC CRISPR QC provides an analytics platform that delivers insights for biotechnology research. Biotech San Diego Series A $10.0M 2024-01-04 $12.5M Serra Ventures, Xcellerant Ventures 11 to 50 2021
Kimia Therapeutics Kimia is a drug discovery company that applies high throughput precision chemistry. Biotech Berkeley Series A $55.0M 2023-12-19 $55.0M Horizons Ventures, The Column Group, Dimension Capital 11 to 50 2022
Cytonus Therapeutics Cytonus Therapeutics develops novel therapeutics using its proprietary drug delivery platform. Artificial intelligence Carlsbad Series A $11.7M 2023-11-03 $20.9M National Institutes of Health, Creative Ventures 11 to 50 2018
Aiolos Bio Aiolos Bio is a biotech company developing therapies for respiratory diseases and immune conditions. Biotech San Francisco Series A $245.0M 2023-10-24 $245.0M RA Capital Management, Atlas Venture, Forbion Capital Partners +2 11 to 50 2023
Rampart Bioscience Rampart Bioscience develops gene medicines for long-lasting treatment of diverse diseases. Biotech La Jolla Series A $85.0M 2023-10-24 $85.0M RA Capital Management, OrbiMed, Forbion Capital Partners +1 11 to 50 2019
Actym Therapeutics, Inc. Actym Therapeutics discovers and develops novel immuno-oncology therapies to treat cancer. Biotech Berkeley Series A $25.5M 2023-10-18 $59.5M Korea Investment Partners, Boehringer Ingelheim Venture Fund, Illumina Ventures +2 11 to 50 2017
Pow.bio Pow.bio provides genetically engineered microbes for fermentation scientists. Biotech Berkeley Series A $9.7M 2023-10-04 $11.5M National Science Foundation, Climate Capital, Cantos +2 11 to 50 2019

Table 1. Biotech startups that raised Series A in California, United States: the 30 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 366.

Largest rounds

Last 12 months
10 rows
# Company What they do Sector City Last round Amount Date Total raised Investors Employees Founded
1 Integrated Biosciences Integrated Bio develops multimodal biological datasets and AI for drug discovery against age-related diseases. Artificial intelligence Redwood City Series A $68.4M 2026-08-05 $85.6M Root Ventures, Reinforced Ventures, Mission BioCapital +2 11 to 50 2022
2 TwoStep Therapeutics TwoStep Therapeutics develops tumor-targeting therapeutics for solid tumors. Biotech Palo Alto Series A $62.5M 2026-09-09 $90.1M NFX, 2048 Ventures, Alexandria Venture Investments +1 11 to 50 2023
3 Medra AI Medra AI builds an autonomous scientific experimentation platform that combines robotics with artificial intelligence. Artificial intelligence San Francisco Series A $52.0M 2025-12-11 $63.0M PharmStars 11 to 50 2021
4 Perelel Perelel makes supplements designed for different stages of a woman's reproductive life cycle. Biotech Los Angeles Series A $27.0M 2025-11-20 $41.7M Unilever Ventures, Willow Growth Partners, Selva Ventures 11 to 50 2018
5 Transcripta Bio Transcripta Bio develops drugs at an accelerated pace with reduced risk. Biotech Palo Alto Series A $24.0M 2026-07-22 $34.4M BlueYard Capital, Jazz Venture Partners 11 to 50 2020
6 Condor Software Condor Software is a financial intelligence platform that connects clinical, operational, and financial data in real time. Biotech San Diego Series A $24.0M 2026-03-18 $29.5M Plug and Play, MassChallenge, Pareto Holdings +1 11 to 50 2020
7 Mithrl Mithrl is a software development company that builds custom NGS data workflows on demand. Artificial intelligence San Francisco Series A $20.0M 2026-09-15 $24.0M Bonfire Ventures 51 to 100 2023
8 Probably Genetic Probably Genetic develops treatments aimed at improving the lives of patients with severe, complex diseases. Artificial intelligence San Francisco Series A $12.0M 2026-10-15 $22.9M Y Combinator, Khosla Ventures, TenOneTen Ventures +2 11 to 50 2018
9 ImpriMed ImpriMed provides AI-driven precision medicine services to oncologists and pharmaceutical companies. Artificial intelligence Palo Alto Series A $10.0M 2026-09-18 $44.7M Plug and Play, Pear VC, Draper Associates +1 51 to 100 2017
10 Zafrens Zafrens provides a throughput platform that links molecular profiles to cell phenotypes for drug discovery. Biotech San Diego Series A $6.0M 2026-11-03 $35.0M Liquid 2 Ventures, Global Brain Corporation, BlueYard Capital +2 11 to 50 2022

Table 2. Biotech startups that raised Series A in California, United States: the 10 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most active investors

By companies backed
#InvestorTypeLocation CompaniesShare Funded, 12 monthsLatest
1 Plug and Play Startup accelerator Sunnyvale, United States 5 1% 2 ImpriMed, Condor Software
2 National Science Foundation Entrepreneurship program Alexandria, United States 4 1%
3 Y Combinator Startup accelerator Mountain View, United States 3 1% 1 Probably Genetic
4 Lux Capital Venture capital firm New York, United States 3 1%
5 Andreessen Horowitz Venture capital firm Menlo Park, United States 3 1%
6 New Enterprise Associates Venture capital firm Menlo Park, United States 3 1%
7 F-Prime Venture capital firm Cambridge, United States 3 1%
8 RA Capital Management Startup incubator Boston, United States 3 1%
9 S32 Venture capital firm San Diego, United States 3 1%
10 BlueYard Capital Venture capital firm Berlin, Germany 2 1% 2 Zafrens, Transcripta Bio
11 Liquid 2 Ventures Venture capital firm San Francisco, United States 2 1% 1 Zafrens
12 Khosla Ventures Venture capital firm Menlo Park, United States 2 1% 1 Probably Genetic
13 2048 Ventures Venture capital firm New York, United States 2 1% 1 TwoStep Therapeutics
14 Alexandria Venture Investments Venture capital firm Pasadena, United States 2 1% 1 TwoStep Therapeutics
15 Jazz Venture Partners Venture capital firm San Francisco, United States 2 1% 1 Transcripta Bio

Table 3. Biotech startups that raised Series A in California, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Sectors

SectorsCompaniesShareTotal raised
Health care 306 84% $15.8B
Software 58 16% $2.4B
Artificial intelligence 36 10% $2.1B
Hardware 12 3% $125.8M
Cybersecurity 4 1% $39.2M
Energy 4 1% $337.7M
Fintech 3 1% $48.7M
Commerce 1 0% $41.7M

Table 4. Biotech startups that raised Series A in California, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.

Funding stage

Funding stageCompaniesShareMedian last round
Series A 366 100% $20.0M

Table 5. Biotech startups that raised Series A in California, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Cities

CitiesCompaniesShare
San Francisco 77 21%
San Diego 62 17%
Palo Alto 34 9%
South San Francisco 19 5%
Menlo Park 13 4%
Berkeley 12 3%
Mountain View 12 3%
San Mateo 9 2%
Los Angeles 9 2%
La Jolla 8 2%
Irvine 7 2%
Redwood City 6 2%

Table 6. Biotech startups that raised Series A in California, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.

Rounds by month

Rounds by monthCompaniesShareRaised
November 2026 1 2% $6.0M
October 2026 6 13% $454.1M
September 2026 5 11% $186.5M
August 2026 3 6% $155.9M
July 2026 3 6% $48.3M
June 2026 5 11% $123.4M
May 2026 4 9% $246.9M
March 2026 6 13% $119.4M
February 2026 3 6% $97.8M
January 2026 3 6% $349.0M
December 2025 6 13% $408.6M
November 2025 2 4% $147.0M

Table 7. Biotech startups that raised Series A in California, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.

Most recent round by year

Most recent round by yearCompaniesShareRaised
2026 39 11% $1.8B
2025 44 12% $2.4B
2024 29 8% $1.9B
2023 34 9% $1.1B
2022 36 10% $1.1B
2021 38 10% $4.0B

Table 8. Biotech startups that raised Series A in California, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.

Founding year

Founding yearCompaniesShare
2023 or later 35 10%
2020 to 2022 70 19%
2015 to 2019 126 35%
2010 to 2014 70 19%
Before 2010 63 17%

Table 9. Biotech startups that raised Series A in California, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.

Team size

Team sizeCompaniesShare
1 to 10 102 29%
11 to 50 215 61%
51 to 100 26 7%
101 to 250 9 3%
251 to 500 1 0%
501 to 1,000 1 0%
10,001 or more 1 0%

Table 10. Biotech startups that raised Series A in California, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.

Method

Sources, fields and exclusions of both files: Method.

Questions

How many biotech startups in California, United States whose last round is Series A are on the list?
366, in the file dated 16 November 2026. 47 of them closed their most recent round in the last 12 months.
What does the CSV contain?
One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
How much does the list cost?
$29 one-time for all 366 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
What arrives after payment?
At once: the CSV download link, on the page after payment and by mail.
Can I see rows before buying?
The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
How current is the data?
The file is dated 16 November 2026. The download link serves the current file each time it is opened.

Biotech startups that raised Series A in California, United States: 366 rows, CSV, $29 one-time.

At once: the CSV download link, on the page after payment and by mail.

Columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.

With founder contacts: $199 one-time. List CSV right after payment; up to 2 verified founder or CEO emails per company compiled to order within 24 hours.

Not sure about the data?

Download a free 10-row sample first. No account, no payment.

Biotech at other stages in California

Other sectors that raised Series A in California

Cite: FundingWatcher, 366 biotech companies in California, United States whose most recent round is Series A, 16 November 2026. https://fundingwatcher.com/startups/biotech/series-a/california-united-states/